Senators Question President’s Pick for OIRA Administrator
Howard Shelanski questioned on delays, retrospective review, and role for cost-benefit analysis.
Using a Compliance Cost Cap to Constrain Regulation
Forthcoming paper proposes firm limits be set on costs of regulatory policy.
FTC Report Shows Increase in Pay-for-Delay Drug Settlements
Agency report indicates that potentially anti-competitive drug settlements are on the rise.
Institutionalizing Regulatory Lookback
Obama’s next OIRA Administrator should act to embed retrospective evaluation into the regulatory process.
Would Two Presidents be Better than One?
PPR seminar speaker makes a case for a dual presidency to break through partisan gridlock.
OMB Releases Draft of Annual Report on Regulation’s Impacts
Major rules, especially EPA’s, potentially create enormous net benefits.
Report Recommends Ways to Improve Regulatory Science
Study for ACUS examines steps agencies should take when using scientific analysis.
We Live in an Interagency World
Despite conventional wisdom, agency coordination can sometimes improve presidential control.
Policy Entrepreneurs: The Power of Audacity
What can the efforts of a single former OIRA official teach about making broad institutional changes?
Congress Considers Limits on “Sue and Settle” Lawsuits
Republicans introduce bill limiting settlements of regulatory lawsuits.
Who Is Running OIRA?
Former EPA official questions review process during transition to new “regulatory czar” at OIRA.